FLUAD TETRA Suspension for injection in pre-filled syringe Ref.[27852] Active ingredients: Influenza, inactivated, surface antigen

Source: European Medicines Agency (EU)  Revision Year: 2023  Publisher: Seqirus Netherlands B.V., Paasheuvelweg 28, 1105 BJ Amsterdam, The Netherlands

Product name and form

Fluad Tetra, suspension for injection in pre-filled syringe.

Influenza vaccine (surface antigen, inactivated, adjuvanted).

Pharmaceutical Form

Suspension for injection in pre-filled syringe (injection).

Milky-white suspension.

Qualitative and quantitative composition

Influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains*:

 Per 0.5 ml dose
A/Victoria/4897/2022 (H1N1)pdm09-like strain
(A/Victoria/4897/2022 IVR-238)
15 micrograms HA**
A/Darwin/9/2021 (H3N2) -like strain
(A/Darwin/6/2021 IVR-227)
15 micrograms HA**
B/Austria/1359417/2021-like strain
(B/Austria/1359417/2021 BVR-26)
15 micrograms HA**
B/Phuket/3073/2013-like strain
(B/Phuket/3073/2013 BVR‐1B)
15 micrograms HA**

* propagated in fertilised hens' eggs from healthy chicken flocks and adjuvanted with MF59C.1
** haemagglutinin

Adjuvant MF59C.1 containing per 0.5 ml dose: squalene (9.75 mg), polysorbate 80 (1.175 mg), sorbitan trioleate (1.175 mg), sodium citrate (0.66 mg) and citric acid (0.04 mg).

This vaccine complies with the WHO recommendations (Northern Hemisphere) and EU
recommendation for the 2023/2024 season

Fluad Tetra may contain traces of eggs such as ovalbumin or chicken proteins, kanamycin and neomycin sulphate, formaldehyde, hydrocortisone, cetyltrimethylammonium bromide (CTAB) which are used during the manufacturing process (see section 4.3).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Influenza, inactivated, surface antigen
List of Excipients

For adjuvant: see also section 2.

Sodium chloride
Potassium chloride
Potassium dihydrogen phosphate
Disodium phosphate dihydrate
Magnesium chloride hexahydrate
Calcium chloride dihydrate
Water for injections

Pack sizes and marketing

0.5 ml of suspension for injection in pre-filled syringe (type I glass) with a plunger stopper (bromobutyl rubber), presented with or without needle.

Pack of 1 pre-filled syringe with needle
Pack of 1 pre-filled syringe without needle
Pack of 10 pre-filled syringes with needles
Pack of 10 pre-filled syringes without needles

Not all pack sizes may be marketed.

Marketing authorization holder

Seqirus Netherlands B.V., Paasheuvelweg 28, 1105 BJ Amsterdam, The Netherlands

Marketing authorization dates and numbers

EU/1/20/1433/001
EU/1/20/1433/002
EU/1/20/1433/003
EU/1/20/1433/004

Date of first authorisation: 20 May 2020

Drugs

Drug Countries
FLUAD TETRA Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.